Arrowstreet Capital
HRMY icon

Arrowstreet Capital’s Harmony Biosciences HRMY Stock Holding History

Arrowstreet Capital’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.7M Sell
1,382,113
-109,492
-7% -$3.59M 0.02% 568
2025
Q4 		$55.8M Buy
1,491,605
+196,224
+15% +$6.45M 0.03% 451
2025
Q3 		$35.7M Buy
1,295,381
+388,472
+43% +$13.4M 0.02% 557
2025
Q2 		$28.7M Buy
906,909
+508,498
+128% +$16.4M 0.02% 572
2025
Q1 		$13.2M Buy
398,411
+101,793
+34% +$3.65M 0.01% 726
2024
Q4 		$10.2M Sell
296,618
-20,948
-7% -$720K 0.01% 819
2024
Q3 		$12.7M Buy
+317,566
New +$11.2M 0.01% 680
2021
Q2 		– Sell
-17,134
Closed -$566K – 2029
2021
Q1 		$566K Buy
+17,134
New +$601K ﹤0.01% 1965

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return